English

OCUGEN, INC.

EDGAR

HSGX Current report (8-K) · filed 2026-10-15

Annual consolidated revenue for 2025: about USD 4.413M, using the latest reported figures. The previous period, 2024, was about USD 4.055M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.49 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 1488000 USD Source

Operating margin

-1,105.11%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -16444000 USD Source
Revenue: 1488000 USD Source

Operating cash flow

-12.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -33992000 USD Source
Operating Cash Flow: -21794000 USD Source

Free cash flow

-12.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -33992000 USD Source
Operating Cash Flow: -21794000 USD Source
Capital Expenditure: 27000 USD Source
Capital Expenditure: 6000 USD Source

Cash and cash equivalents: 100 million USD 2026-06-30 Source
Exact value

100051000 USD
Long-term debt including current maturities: 1.71 million USD 2021-12-31 Source
Exact value

1712000 USD
Shares outstanding: 339 million shares 2026-06-30 Source
Exact value

339044893 shares

Reported share-count change

16.03% · 46.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

292192061 shares · 2025-06-30· Source
339044893 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.58 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 1752000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 4413000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 4606000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 1533000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 1488000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-81.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -20051000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -67800000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -50100000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -19177000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -24877000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-60.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -43003000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -30087000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -56964000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -43003000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -21794000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -33992000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -21794000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

153 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 150000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 59000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 185000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 150000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 6000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 6000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-61 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -43003000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -30087000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -56964000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -43003000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -21794000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -33992000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -21794000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 150000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 59000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 185000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 150000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 6000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 27000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 6000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-15.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2021-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+8.8%

Prior period

USD 4.06 million

2024-01-01 – 2024-12-31
Current period

USD 4.41 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

4413000 − 4055000 = 358000 USD

4055000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
4413000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Year-over-year change in Revenue: 358000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4413000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1327641 Filing: 000162828026014435 Input fundies:Revenue: 4055000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1328296 Filing: 000162828026014435
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 13.7 million

Prior period

−USD 54.1 million

2024-01-01 – 2024-12-31
Current period

−USD 67.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-67800000 − -54100000 = -13700000 USD

-54100000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-67800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Year-over-year change in Net income: -13700000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -67800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1493704 Filing: 000162828026014435 Input fundies:NetIncome: -54100000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1493859 Filing: 000162828026014435
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 14.82 million

Prior period

−USD 42.14 million

2024-01-01 – 2024-12-31
Current period

−USD 56.96 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-56964000 − -42142000 = -14822000 USD

-42142000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-56964000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Year-over-year change in Operating cash flow: -14822000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -56964000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1459386 Filing: 000162828026014435 Input fundies:OperatingCashFlow: -42142000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1460038 Filing: 000162828026014435
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-94.5%

Prior period

USD 3.39 million

2024-01-01 – 2024-12-31
Current period

USD 185,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

185000 − 3385000 = -3200000 USD

3385000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
185000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Year-over-year change in Capital expenditure: -3200000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 185000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1461662 Filing: 000162828026014435 Input fundies:CapitalExpenditure: 3385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1462221 Filing: 000162828026014435
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 4.41 million 100% of revenue
Operating costs Derived USD 67.33 million 1,526% of revenue
Operating income −USD 62.92 million −1,426% of revenue
Tax, interest and other Derived USD 4.88 million 111% of revenue
Net income −USD 67.8 million −1,536% of revenue

Cash

Operating cash flow −USD 56.96 million −1,291% of revenue
Capital expenditure USD 185,000 4.2% of revenue
Free cash flow Derived −USD 57.15 million −1,295% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Operating loss: operating costs were 49,600% of revenue.
2021 Not shown: operating income or net income is not reported.
2022 Operating loss: operating costs were 3,680% of revenue.
2023 Operating loss: operating costs were 1,186% of revenue.
2024 Operating loss: operating costs were 1,450% of revenue.
2025 Operating loss: operating costs were 1,526% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	0	30307000 Derived	-30307000	-14099000 Derived	-16208000	-26056000 Derived	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -30307000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -16208000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -25736000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 320000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	24950000 Derived	-24950000	1464000 Derived	-26414000	-23296000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -24950000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -26414000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -23020000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 276000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	16140508 Derived	-16140508	2059492 Derived	-18200000	-11707957 Derived	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -16140508 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -18200000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -11630543 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 77414 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	0	14163000 Derived	-14163000	6080000 Derived	-20243000	-16923000 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -14163000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -20243000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -16893000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 30000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	43000	21328000 Derived	-21285000	537000 Derived	-21822000	-15016000 Derived	Source 2020-01-01 – 2020-12-31: 43000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -21285000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -21822000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -14709000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 307000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	0	58028000 Derived	-58028000	337000 Derived	-58365000	-48880000 Derived	Source 2021-01-01 – 2021-12-31: 0 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -58028000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -58365000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -47941000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 939000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	2488000	91559000 Derived	-89071000	-2267000 Derived	-86804000	-64536000 Derived	Source 2022-01-01 – 2022-12-31: 2488000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -89071000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -86804000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -60079000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 4457000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	6036000	71567000 Derived	-65531000	-2431000 Derived	-63100000	-72530000 Derived	Source 2023-01-01 – 2023-12-31: 6036000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -65531000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -63100000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -62054000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 10476000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	4055000	58812000 Derived	-54757000	-657000 Derived	-54100000	-45527000 Derived	Source 2024-01-01 – 2024-12-31: 4055000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -54757000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -54100000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -42142000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 3385000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	4413000	67329000 Derived	-62916000	4884000 Derived	-67800000	-57149000 Derived	Source 2025-01-01 – 2025-12-31: 4413000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -62916000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -67800000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -56964000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 185000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.4M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	0	Revenue: 0 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	43000	Revenue: 43000 Open source
20212021-12-31	Revenue	0	Revenue: 0 Open source
20222022-12-31	Revenue	2488000	Revenue: 2488000 Open source
20232023-12-31	Revenue	6036000	Revenue: 6036000 Open source
20242024-12-31	Revenue	4055000	Revenue: 4055000 Open source
20252025-12-31	Revenue	4413000	Revenue: 4413000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

8.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 43000 Open source Revenue: 0 Open source
20212021-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 43000 Open source
20222022-12-31	Year over year	No prior comparable period	Revenue: 2488000 Open source Revenue: 0 Open source
20232023-12-31	Year over year	142.6%	Revenue: 6036000 Open source Revenue: 2488000 Open source
20242024-12-31	Year over year	-32.8%	Revenue: 4055000 Open source Revenue: 6036000 Open source
20252025-12-31	Year over year	8.8%	Revenue: 4413000 Open source Revenue: 4055000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,425.7% 2025

Net margin -1,536.4% 2025

Free cash flow margin -1,295% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	Not reported	Operating Income: -30307000 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -24950000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -16140508 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -14163000 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	-49,500%	Operating Income: -21285000 Open source Revenue: 43000 Open source
20212021-12-31	Operating margin	Not reported	Operating Income: -58028000 Open source Revenue: 0 Open source
20222022-12-31	Operating margin	-3,580%	Operating Income: -89071000 Open source Revenue: 2488000 Open source
20232023-12-31	Operating margin	-1,085.7%	Operating Income: -65531000 Open source Revenue: 6036000 Open source
20242024-12-31	Operating margin	-1,350.4%	Operating Income: -54757000 Open source Revenue: 4055000 Open source
20252025-12-31	Operating margin	-1,425.7%	Operating Income: -62916000 Open source Revenue: 4413000 Open source
20162016-12-31	Net margin	Not reported	Net Income: -16208000 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -26414000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -18200000 Open source Revenue: 0 Open source
20192019-12-31	Net margin	Not reported	Net Income: -20243000 Open source Revenue: 0 Open source
20202020-12-31	Net margin	-50,748.8%	Net Income: -21822000 Open source Revenue: 43000 Open source
20212021-12-31	Net margin	Not reported	Net Income: -58365000 Open source Revenue: 0 Open source
20222022-12-31	Net margin	-3,488.9%	Net Income: -86804000 Open source Revenue: 2488000 Open source
20232023-12-31	Net margin	-1,045.4%	Net Income: -63100000 Open source Revenue: 6036000 Open source
20242024-12-31	Net margin	-1,334.2%	Net Income: -54100000 Open source Revenue: 4055000 Open source
20252025-12-31	Net margin	-1,536.4%	Net Income: -67800000 Open source Revenue: 4413000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -25736000 Open source Capital Expenditure: 320000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -23020000 Open source Capital Expenditure: 276000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -11630543 Open source Capital Expenditure: 77414 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -16893000 Open source Capital Expenditure: 30000 Open source
20202020-12-31	Free cash flow margin	-34,920.9%	Revenue: 43000 Open source Operating Cash Flow: -14709000 Open source Capital Expenditure: 307000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -47941000 Open source Capital Expenditure: 939000 Open source
20222022-12-31	Free cash flow margin	-2,593.9%	Revenue: 2488000 Open source Operating Cash Flow: -60079000 Open source Capital Expenditure: 4457000 Open source
20232023-12-31	Free cash flow margin	-1,201.6%	Revenue: 6036000 Open source Operating Cash Flow: -62054000 Open source Capital Expenditure: 10476000 Open source
20242024-12-31	Free cash flow margin	-1,122.7%	Revenue: 4055000 Open source Operating Cash Flow: -42142000 Open source Capital Expenditure: 3385000 Open source
20252025-12-31	Free cash flow margin	-1,295%	Revenue: 4413000 Open source Operating Cash Flow: -56964000 Open source Capital Expenditure: 185000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -57M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-25736000	Operating Cash Flow: -25736000 Open source
20172017-12-31	Operating cash flow	-23020000	Operating Cash Flow: -23020000 Open source
20182018-12-31	Operating cash flow	-11630543	Operating Cash Flow: -11630543 Open source
20192019-12-31	Operating cash flow	-16893000	Operating Cash Flow: -16893000 Open source
20202020-12-31	Operating cash flow	-14709000	Operating Cash Flow: -14709000 Open source
20212021-12-31	Operating cash flow	-47941000	Operating Cash Flow: -47941000 Open source
20222022-12-31	Operating cash flow	-60079000	Operating Cash Flow: -60079000 Open source
20232023-12-31	Operating cash flow	-62054000	Operating Cash Flow: -62054000 Open source
20242024-12-31	Operating cash flow	-42142000	Operating Cash Flow: -42142000 Open source
20252025-12-31	Operating cash flow	-56964000	Operating Cash Flow: -56964000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -57.1M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-26056000	Operating Cash Flow: -25736000 Open source Capital Expenditure: 320000 Open source
20172017-12-31	Free cash flow	-23296000	Operating Cash Flow: -23020000 Open source Capital Expenditure: 276000 Open source
20182018-12-31	Free cash flow	-11707957	Operating Cash Flow: -11630543 Open source Capital Expenditure: 77414 Open source
20192019-12-31	Free cash flow	-16923000	Operating Cash Flow: -16893000 Open source Capital Expenditure: 30000 Open source
20202020-12-31	Free cash flow	-15016000	Operating Cash Flow: -14709000 Open source Capital Expenditure: 307000 Open source
20212021-12-31	Free cash flow	-48880000	Operating Cash Flow: -47941000 Open source Capital Expenditure: 939000 Open source
20222022-12-31	Free cash flow	-64536000	Operating Cash Flow: -60079000 Open source Capital Expenditure: 4457000 Open source
20232023-12-31	Free cash flow	-72530000	Operating Cash Flow: -62054000 Open source Capital Expenditure: 10476000 Open source
20242024-12-31	Free cash flow	-45527000	Operating Cash Flow: -42142000 Open source Capital Expenditure: 3385000 Open source
20252025-12-31	Free cash flow	-57149000	Operating Cash Flow: -56964000 Open source Capital Expenditure: 185000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

128% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	62.4%	Total Liabilities: 22511000 Open source Total Assets: 36078000 Open source
20172017-12-31	Liabilities / assets	202.1%	Total Liabilities: 22303000 Open source Total Assets: 11035000 Open source
20182018-12-31	Liabilities / assets	617.9%	Total Liabilities: 15163772 Open source Total Assets: 2454233 Open source
20192019-12-31	Liabilities / assets	34.4%	Total Liabilities: 5789035 Open source Total Assets: 16807446 Open source
20202020-12-31	Liabilities / assets	21.3%	Total Liabilities: 5826000 Open source Total Assets: 27376000 Open source
20212021-12-31	Liabilities / assets	9.4%	Total Liabilities: 9943000 Open source Total Assets: 105761000 Open source
20222022-12-31	Liabilities / assets	31.9%	Total Liabilities: 34651000 Open source Total Assets: 108632000 Open source
20232023-12-31	Liabilities / assets	37.2%	Total Liabilities: 23983000 Open source Total Assets: 64547000 Open source
20242024-12-31	Liabilities / assets	64.1%	Total Liabilities: 52810000 Open source Total Assets: 82442000 Open source
20252025-12-31	Liabilities / assets	128%	Total Liabilities: 55682000 Open source Total Assets: 43516000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.06× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	6.2×	Current Assets: 32081000 Open source Current Liabilities: 5171000 Open source
20172017-12-31	Current assets / current liabilities	2.15×	Current Assets: 8175000 Open source Current Liabilities: 3805000 Open source
20182018-12-31	Current assets / current liabilities	0.14×	Current Assets: 1941635 Open source Current Liabilities: 14109586 Open source
20192019-12-31	Current assets / current liabilities	3.47×	Current Assets: 15766219 Open source Current Liabilities: 4543959 Open source
20202020-12-31	Current assets / current liabilities	7.16×	Current Assets: 25878000 Open source Current Liabilities: 3614000 Open source
20212021-12-31	Current assets / current liabilities	14.66×	Current Assets: 102646000 Open source Current Liabilities: 7000000 Open source
20222022-12-31	Current assets / current liabilities	3.45×	Current Assets: 98492000 Open source Current Liabilities: 28531000 Open source
20232023-12-31	Current assets / current liabilities	2.51×	Current Assets: 42971000 Open source Current Liabilities: 17089000 Open source
20242024-12-31	Current assets / current liabilities	2.86×	Current Assets: 61682000 Open source Current Liabilities: 21588000 Open source
20252025-12-31	Current assets / current liabilities	1.06×	Current Assets: 24340000 Open source Current Liabilities: 23043000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 16.21 million Exact value Exact value: -16208000 USD 2016-01-01 – 2016-12-31: -16208000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2016-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -16208000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16208000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000156459018005711/hsgx-20171231.xml#115664 Filing: 000156459018005711 The citation records this snapshot. The page link may show a newer release later.	−USD 25.74 million Exact value Exact value: -25736000 USD 2016-01-01 – 2016-12-31: -25736000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2016-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -25736000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25736000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000156459018005711/hsgx-20171231.xml#134088 Filing: 000156459018005711 The citation records this snapshot. The page link may show a newer release later.	USD 320,000 Exact value Exact value: 320000 USD 2016-01-01 – 2016-12-31: 320000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2016-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 320000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 320000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000156459018005711/hsgx-20171231.xml#134549 Filing: 000156459018005711 The citation records this snapshot. The page link may show a newer release later.	−USD 26.06 million Calculation and evidence -25736000 − 320000 USD Exact free cash flow: -26056000 USD 2016-01-01 – 2016-12-31: -25736000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 320000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2016-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -26056000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25736000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000156459018005711/hsgx-20171231.xml#134088 Filing: 000156459018005711 Input fundies:CapitalExpenditure: 320000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000156459018005711/hsgx-20171231.xml#134549 Filing: 000156459018005711 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 26.41 million Exact value Exact value: -26414000 USD 2017-01-01 – 2017-12-31: -26414000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2017-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -26414000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26414000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000119312519173827/hsgx-20190331.xml#534605 Filing: 000119312519173827 The citation records this snapshot. The page link may show a newer release later.	−USD 23.02 million Exact value Exact value: -23020000 USD 2017-01-01 – 2017-12-31: -23020000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2017-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -23020000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23020000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000119312519173827/hsgx-20190331.xml#534336 Filing: 000119312519173827 The citation records this snapshot. The page link may show a newer release later.	USD 276,000 Exact value Exact value: 276000 USD 2017-01-01 – 2017-12-31: 276000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2017-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 276000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 276000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000119312519173827/hsgx-20190331.xml#536014 Filing: 000119312519173827 The citation records this snapshot. The page link may show a newer release later.	−USD 23.3 million Calculation and evidence -23020000 − 276000 USD Exact free cash flow: -23296000 USD 2017-01-01 – 2017-12-31: -23020000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 276000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2017-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -23296000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23020000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000119312519173827/hsgx-20190331.xml#534336 Filing: 000119312519173827 Input fundies:CapitalExpenditure: 276000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000119312519173827/hsgx-20190331.xml#536014 Filing: 000119312519173827 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 18.2 million Exact value Exact value: -18200000 USD 2018-01-01 – 2018-12-31: -18200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2018-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -18200000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18200000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828020004221/ocgn-20191231.htm#2407368 Filing: 000162828020004221 The citation records this snapshot. The page link may show a newer release later.	−USD 11.63 million Exact value Exact value: -11630543 USD 2018-01-01 – 2018-12-31: -11630543 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2018-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -11630543 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11630543 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828020004221/ocgn-20191231.htm#1808009 Filing: 000162828020004221 The citation records this snapshot. The page link may show a newer release later.	USD 77,414 Exact value Exact value: 77414 USD 2018-01-01 – 2018-12-31: 77414 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2018-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 77414 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 77414 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828020004221/ocgn-20191231.htm#1811613 Filing: 000162828020004221 The citation records this snapshot. The page link may show a newer release later.	−USD 11.71 million Calculation and evidence -11630543 − 77414 USD Exact free cash flow: -11707957 USD 2018-01-01 – 2018-12-31: -11630543 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 77414 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2018-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -11707957 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11630543 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828020004221/ocgn-20191231.htm#1808009 Filing: 000162828020004221 Input fundies:CapitalExpenditure: 77414 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828020004221/ocgn-20191231.htm#1811613 Filing: 000162828020004221 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 20.24 million Exact value Exact value: -20243000 USD 2019-01-01 – 2019-12-31: -20243000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2019-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -20243000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20243000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#2327929 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	−USD 16.89 million Exact value Exact value: -16893000 USD 2019-01-01 – 2019-12-31: -16893000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2019-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -16893000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16893000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1688197 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	USD 30,000 Exact value Exact value: 30000 USD 2019-01-01 – 2019-12-31: 30000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2019-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 30000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1691956 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	−USD 16.92 million Calculation and evidence -16893000 − 30000 USD Exact free cash flow: -16923000 USD 2019-01-01 – 2019-12-31: -16893000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 30000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2019-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -16923000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16893000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1688197 Filing: 000162828022004085 Input fundies:CapitalExpenditure: 30000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1691956 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 21.82 million Exact value Exact value: -21822000 USD 2020-01-01 – 2020-12-31: -21822000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2020-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -21822000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21822000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#2326677 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	−USD 14.71 million Exact value Exact value: -14709000 USD 2020-01-01 – 2020-12-31: -14709000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2020-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -14709000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14709000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1687148 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	USD 307,000 Exact value Exact value: 307000 USD 2020-01-01 – 2020-12-31: 307000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2020-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 307000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 307000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1691003 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.	−USD 15.02 million Calculation and evidence -14709000 − 307000 USD Exact free cash flow: -15016000 USD 2020-01-01 – 2020-12-31: -14709000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 307000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2020-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -15016000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14709000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1687148 Filing: 000162828022004085 Input fundies:CapitalExpenditure: 307000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828022004085/ocgn-20211231.htm#1691003 Filing: 000162828022004085 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 58.37 million Exact value Exact value: -58365000 USD 2021-01-01 – 2021-12-31: -58365000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2021-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -58365000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58365000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828023005382/ocgn-20221231.htm#2153051 Filing: 000162828023005382 The citation records this snapshot. The page link may show a newer release later.	−USD 47.94 million Exact value Exact value: -47941000 USD 2021-01-01 – 2021-12-31: -47941000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2021-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -47941000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47941000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828023005382/ocgn-20221231.htm#1578302 Filing: 000162828023005382 The citation records this snapshot. The page link may show a newer release later.	USD 939,000 Exact value Exact value: 939000 USD 2021-01-01 – 2021-12-31: 939000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2021-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 939000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 939000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828023005382/ocgn-20221231.htm#1583223 Filing: 000162828023005382 The citation records this snapshot. The page link may show a newer release later.	−USD 48.88 million Calculation and evidence -47941000 − 939000 USD Exact free cash flow: -48880000 USD 2021-01-01 – 2021-12-31: -47941000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 939000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2021-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -48880000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47941000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828023005382/ocgn-20221231.htm#1578302 Filing: 000162828023005382 Input fundies:CapitalExpenditure: 939000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828023005382/ocgn-20221231.htm#1583223 Filing: 000162828023005382 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 86.8 million Exact value Exact value: -86804000 USD 2022-01-01 – 2022-12-31: -86804000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2022-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -86804000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -86804000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828024016378/ocgn-20231231.htm#1980286 Filing: 000162828024016378 The citation records this snapshot. The page link may show a newer release later.	−USD 60.08 million Exact value Exact value: -60079000 USD 2022-01-01 – 2022-12-31: -60079000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2022-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -60079000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -60079000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828024016378/ocgn-20231231.htm#1954727 Filing: 000162828024016378 The citation records this snapshot. The page link may show a newer release later.	USD 4.46 million Exact value Exact value: 4457000 USD 2022-01-01 – 2022-12-31: 4457000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2022-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 4457000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4457000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828024016378/ocgn-20231231.htm#1497924 Filing: 000162828024016378 The citation records this snapshot. The page link may show a newer release later.	−USD 64.54 million Calculation and evidence -60079000 − 4457000 USD Exact free cash flow: -64536000 USD 2022-01-01 – 2022-12-31: -60079000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 4457000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2022-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -64536000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -60079000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828024016378/ocgn-20231231.htm#1954727 Filing: 000162828024016378 Input fundies:CapitalExpenditure: 4457000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828024016378/ocgn-20231231.htm#1497924 Filing: 000162828024016378 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 63.1 million Exact value Exact value: -63100000 USD 2023-01-01 – 2023-12-31: -63100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2023-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -63100000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -63100000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828025010271/ocgn-20241231.htm#1467070 Filing: 000162828025010271 The citation records this snapshot. The page link may show a newer release later.	−USD 62.05 million Exact value Exact value: -62054000 USD 2023-01-01 – 2023-12-31: -62054000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2023-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -62054000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62054000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828025010271/ocgn-20241231.htm#1430112 Filing: 000162828025010271 The citation records this snapshot. The page link may show a newer release later.	USD 10.48 million Exact value Exact value: 10476000 USD 2023-01-01 – 2023-12-31: 10476000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2023-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 10476000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10476000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828025010271/ocgn-20241231.htm#1434932 Filing: 000162828025010271 The citation records this snapshot. The page link may show a newer release later.	−USD 72.53 million Calculation and evidence -62054000 − 10476000 USD Exact free cash flow: -72530000 USD 2023-01-01 – 2023-12-31: -62054000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 10476000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2023-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -72530000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62054000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828025010271/ocgn-20241231.htm#1430112 Filing: 000162828025010271 Input fundies:CapitalExpenditure: 10476000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828025010271/ocgn-20241231.htm#1434932 Filing: 000162828025010271 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 54.1 million Exact value Exact value: -54100000 USD 2024-01-01 – 2024-12-31: -54100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2024-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -54100000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54100000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1493859 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	−USD 42.14 million Exact value Exact value: -42142000 USD 2024-01-01 – 2024-12-31: -42142000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2024-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -42142000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -42142000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1460038 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	USD 3.39 million Exact value Exact value: 3385000 USD 2024-01-01 – 2024-12-31: 3385000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2024-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 3385000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1462221 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	−USD 45.53 million Calculation and evidence -42142000 − 3385000 USD Exact free cash flow: -45527000 USD 2024-01-01 – 2024-12-31: -42142000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 3385000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2024-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -45527000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -42142000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1460038 Filing: 000162828026014435 Input fundies:CapitalExpenditure: 3385000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1462221 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 67.8 million Exact value Exact value: -67800000 USD 2025-01-01 – 2025-12-31: -67800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Net Income: -67800000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -67800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1493704 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	−USD 56.96 million Exact value Exact value: -56964000 USD 2025-01-01 – 2025-12-31: -56964000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Operating Cash Flow: -56964000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56964000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1459386 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	USD 185,000 Exact value Exact value: 185000 USD 2025-01-01 – 2025-12-31: 185000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Capital Expenditure: 185000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 185000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1461662 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.	−USD 57.15 million Calculation and evidence -56964000 − 185000 USD Exact free cash flow: -57149000 USD 2025-01-01 – 2025-12-31: -56964000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 185000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · OCUGEN, INC. · 2025-12-31 OCUGEN, INC. (edgar:1372299) Free cash flow: -57149000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:27Z Snapshot: f05b26acb058022938dfa79f9553ff449deebd994e40d018a7604fe7bd1027bf Dimensions: Consolidated View: https://fundies.io/companies/edgar/1372299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56964000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1459386 Filing: 000162828026014435 Input fundies:CapitalExpenditure: 185000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1372299/000162828026014435/ocgn-20251231.htm#1461662 Filing: 000162828026014435 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

131 filings · 3,041 latest values · 3,041 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001372299, 1372299, HSGX, OCGN, edgar:1372299

Also known as HISTOGENICS CORP, Histogenics Corporation, OCUGEN, INC., OCUGEN, INC., Ocugen, Inc.

OCUGEN, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation